Glioma

You have access
Post-resection Cavity Lavage of High Grade Glioma With a Novel Drug Combination: A Case Report
SIBHI GANAPATHY, NEELAM K. VENKATARAMANA, ANMOL NAGARAJ, GEORGE PANAYOTOU, CHRISTOS PANOTOPOULOS and GUNNAR RONQUIST

Anticancer Research August 2023, 43 (8) 3583-3588; DOI: https://doi.org/10.21873/anticanres.16537
You have access
Arsenite-induced Radiosensitization of Glioma Cells Is Dependent on p53 Deficiency
YASUHARU NINOMIYA, TATSUHIKO IMAOKA, KAZUHIRO DAINO, SHIZUKO KAKINUMA and TETSUO NAKAJIMA

Anticancer Research June 2023, 43 (6) 2551-2559; DOI: https://doi.org/10.21873/anticanres.16422
You have access
Expression of ENO1 Is Up-regulated in Low-grade Glioma and Positively Correlated With Meningioma Grade
DANG THUY DIEM DINH, SASKIA KUHL, LUKAS GÖRTZ, ROLAND GOLDBRUNNER and MARCO TIMMER

Anticancer Research May 2022, 42 (5) 2319-2326; DOI: https://doi.org/10.21873/anticanres.15711
You have access
Oncogenic Fusions in Gliomas: An Institutional Experience
JIRI POLIVKA, MARIAN SVAJDLER, VLADIMIR PRIBAN, JAN MRACEK, PETR KASIK, PETR MARTINEK, NIKOLA PTAKOVA, MAHYAR SHARIF BAGHERI, DATTATRYA SHETTI, MARTIN PESTA, PAVEL POTUZNIK and ONDREJ TOPOLCAN

Anticancer Research April 2022, 42 (4) 1933-1939; DOI: https://doi.org/10.21873/anticanres.15671
Open Access
Pineal Region Gliomas: A Systematic Review of Clinical Features and Treatment Outcomes
OTHMAN BIN ALAMER, PAOLO PALMISCIANO, SCOTT E. ROWE, ADITYA DUTTA GUPTA, MARYAM HAIDER, MOHAMMED ALDUHAYMI, AARON A. COHEN-GADOL, KENNY YU, TAREK Y. EL-AHMADIEH and ALI S. HAIDER

Anticancer Research March 2022, 42 (3) 1189-1198; DOI: https://doi.org/10.21873/anticanres.15585
You have access
Death Receptor 6 as a Prognostic Marker in Low-grade Glioma
SARAH K. STEGMANN, SASKIA KUHL, NAM GYU IM, DANG THUY DIEM-DINH, LUKAS GOERTZ, ROLAND GOLDBRUNNER and MARCO TIMMER

Anticancer Research March 2022, 42 (3) 1237-1245; DOI: https://doi.org/10.21873/anticanres.15591
You have access
Large Animal Models of Glioma: Current Status and Future Prospects
WILLIAM H. HICKS, CYLAINA E. BIRD, MARK N. PERNIK, ALI S. HAIDER, AKSHARKUMAR DOBARIYA, KALIL G. ABDULLAH, SALAH G. AOUN, R. TIMOTHY BENTLEY, AARON A. COHEN-GADOL, ROBERT M. BACHOO, BRUCE E. MICKEY, JUAN M. PASCUAL and TAREK Y. EL AHMADIEH

Anticancer Research November 2021, 41 (11) 5343-5353; DOI: https://doi.org/10.21873/anticanres.15347
You have access
DNA-binding Cell-penetrating Peptide-based TRAIL Over-expression in Adipose Tissue-derived Mesenchymal Stem Cells Inhibits Glioma U251MG Growth
JAESIK SHIN, SOON KOO BAIK, YONGDAE YOON, SOONJAE HWANG, JOON HYUNG SOHN, MINJEONG JO, WOO-SEUNG KIM, KI-JONG RHEE, KUM WHANG and YOUNG WOO EOM

Anticancer Research June 2021, 41 (6) 2859-2866; DOI: https://doi.org/10.21873/anticanres.15067
You have access
Synthetic Betulin Derivatives Inhibit Growth of Glioma Cells In Vitro
SYLWIA K. KRÓL, EWA BĘBENEK, ADRIANNA SŁAWIŃSKA-BRYCH, MAGDALENA DMOSZYŃSKA-GRANICZKA, STANISŁAW BORYCZKA and ANDRZEJ STEPULAK

Anticancer Research November 2020, 40 (11) 6151-6158; DOI: https://doi.org/10.21873/anticanres.14635
You have access
DRAQ7 as an Alternative to MTT Assay for Measuring Viability of Glioma Cells Treated With Polyphenols
HARCHARAN KAUR ROOPRAI, PATRICK LAWRENCE, SHOLEH KESHAVARZ, POOJA YASHOD, RICHARD W. GULLAN, RICHARD P. SELWAY and DEREK DAVIES

Anticancer Research October 2020, 40 (10) 5427-5436; DOI: https://doi.org/10.21873/anticanres.14553

Main menu

User menu

Search

Glioma

Pages